Staphylococcus aureus Surgical Site Infection Following Unilateral Biportal Endoscopic Spine Surgery: A Two-Case Report - Takeaways - MDSpire

Staphylococcus aureus Surgical Site Infection Following Unilateral Biportal Endoscopic Spine Surgery: A Two-Case Report

  • By

  • Hong, Chunlin

  • Chen, Lingfeng

  • Chen, Huinuan

  • Lin, Yahui

  • Lin, Hong

  • Huang, Zhirong

  • Liu, Xuena

  • Lin, Shiming

  • March 13, 2026

  • 0 min

Share

  • 1

    Staphylococcus aureus is a leading cause of surgical site infections (SSIs) following unilateral biportal endoscopic spine surgery.

  • 2

    Both cases involved inadequate preoperative skin preparation and intraoperative fluid leakage, contributing to deep SSIs.

  • 3

    Patients required readmission, endoscopic debridement, and targeted antibiotic therapy due to confirmed S. aureus infections.

  • 4

    Key risk factors for SSIs included prolonged surgery, inadequate wound care, and breaches in postoperative protocols.

  • 5

    Implementing targeted interventions effectively reduced the incidence of SSIs in subsequent UBE surgeries.

Original Source(s)

Staphylococcus aureus Surgical Site Infection Following Unilateral Biportal Endoscopic Spine Surgery: A Two-Case Report

  • by Hong, Chunlin , Chen, Lingfeng , Chen, Huinuan , Lin, Yahui , Lin, Hong , Huang, Zhirong , Liu, Xuena , Lin, Shiming

  • March 13, 2026

Related Content

Editorial: Pain management in spine surgery

Mandatory Training Modules Deserve a Harder Look

A JAMA Viewpoint argues that 4 million physician-hours spent on compliance modules each year warrants institutional reassessment.

FDA Okays Weekly Option in Achondroplasia

Navepegritide is described as the first therapy to deliver continuous C-type natriuretic peptide exposure over a weekly dosing interval in eligible pediatric patients.